Purple Biotech Ltd.
PPBT.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$208.51K
Close$
Share Statistics
| Market cap | $208,507.00 |
|---|---|
| Enterprise Value | $-4,759,493.00 |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -202.44% |
|---|---|
| Return on Assets | -175.36% |
| Return on Invested Capital | -197.90% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.19 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.06 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Purple Biotech Ltd
10 employees
CEO: Itzhak Israel Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline inc...